miR-761 inhibits human osteosarcoma progression by targeting CXCR1

Shaoyun Wang1, Jinyu Zhang2, Guoping Chen2

  • 1Department of Orthopaedics, The First Affiliated Hospital of Kunming Medical University Kunming, P. R. China.

Insights

microRNA-761 (miR-761) is reduced in osteosarcoma (OS) and targets the oncogene CXCR1. Restoring miR-761 inhibits OS cell proliferation and invasion, suggesting its potential as a therapeutic biomarker.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • microRNAs (miRs) are key regulators of cellular processes.
  • miR-761's role in human cancers is varied, but its function in osteosarcoma (OS) is unclear.
  • CXC receptor-1 (CXCR1) is an oncogene overexpressed in OS.

Purpose of the Study:

  • To investigate the biological role and mechanism of miR-761 in osteosarcoma.
  • To identify miR-761 targets in OS cells.
  • To evaluate miR-761's potential as a diagnostic or therapeutic biomarker for OS.

Main Methods:

  • Quantitative real-time PCR to measure miR-761 expression in OS tissues and cell lines.
  • Bioinformatic analysis, luciferase reporter assays, and Western blot to validate CXCR1 as a direct target of miR-761.
  • Cell proliferation and invasion assays to assess the functional impact of miR-761 in OS.

Main Results:

  • miR-761 expression was significantly downregulated in osteosarcoma tissues and cell lines compared to normal controls.
  • CXC receptor-1 (CXCR1) was identified as a direct and novel target of miR-761.
  • Overexpression of miR-761 suppressed osteosarcoma cell proliferation and invasion, partially via targeting CXCR1.

Conclusions:

  • miR-761 functions as a tumor suppressor in osteosarcoma.
  • The miR-761/CXCR1 axis plays a critical role in osteosarcoma progression.
  • miR-761 represents a potential therapeutic biomarker for osteosarcoma treatment.